HeartFlow is the creator of a cardiac diagnostic platform designed to revolutionize the diagnosis and treatment of coronary artery diseases. This platform utilizes data from regular computerized tomography scans to generate a personalized three-dimensional model of arteries. It further analyzes the effects of blockages on blood flow. This innovative approach enables clinicians to effectively treat patients suffering from significant coronary artery disease while minimizing unnecessary invasive testing.

Investors Include:

Hayfin Capital Management, Wellington Management, U.S. Department of Health and Human Services, Emergent Medical Partners, InterAlpen Partners, Spur Capital Partners, Bain Capital, U.S. Venture Partners, Sandbox Industries, Lifeforce Capital, Baillie Gifford, Sweetwater Private Equity, Rancilio Cube, HealthCare Ventures, SeedFord Partners, Venture Science, Lotus Capital Ventures, Martis Capital Management, Mark Carlson, 3Spoke Capital, Bain Capital Life Sciences, HealthCor Partners Management, Fogarty Innovation, Blue Venture Fund, Capricorn Investment Group.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more

Our available services for this company

Lifetime IncomeCharitable Remainder Trust

Tax SavingsDonor Advised Fund